Science News

CIRCULATION Editor's Picks March 2019
03/21/2019 | CIRCULATON Editor's Picks for March 2019
2019 Guideline on the Primary Prevention of Cardiovascular Disease
03/17/2019 | The purpose of this guideline is to review and consolidate existing recommendations into a single guidance document focused on the primary prevention of atherosclerotic cardiovascular disease (ASCVD).
ATVB | Featured Articles | March 2019
02/28/2019 | Deletion of NF-?B/RelA in Angiotensin II-sensitive mesenchymal cells blocks aortic vascular inflammation and AAA formation and CETP Inhibition with Anacetrapib Decreases Production of Lipoprotein (a) in Mildly Hypercholesterolemic Subjects
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
02/25/2019 | This update to the 2006 Scientific Statement on Cardiovascular Risk Reduction in High-Risk Pediatric Patients discusses presentations that make the young heart more vulnerable to accelerated arteriosclerosis and coronary artery abnormalities.
Cardio-Oncology: Vascular and Metabolic Perspective
02/21/2019 | Cardio-oncology, which focuses on the intersection of heart conditions in patients who have been treated for cancer, has developed as a new discipline within cardiovascular medicine.
From Circulation Research: Atherothrombosis Drugs Compendium
02/15/2019 | CIRCULATION RESEARCH Atherothrombosis Drugs Compendium
New JAHA Featured Articles January 22, 2019
01/31/2019 | New featured articles from JAHA for January 22, 2019
CIRCULATION Editor's Picks December 2018
12/19/2018 | CIRCULATON Editor's Picks for December 2018
Statin Safety and Associated Adverse Events
12/10/2018 | Statins have a major impact in reducing the incidence of cardiovascular diseases (CVD), including stroke and over 30 years of clinical investigation show that statins exhibit few serious adverse effects.
Physical Activity Guidelines for Americans, 2nd edition
11/12/2018 | The American Heart Association is adopting the 2018 physical activity guidelines published by the U.S. Department of Health and Human Services (HHS) which were announced on Monday, Nov. 12, 2018, at the American Heart Association?s flagship meeting Scientific Sessions.
Use of Risk Assessment Tools to Guide Decision-Making in Primary Prev of ASCVD
11/10/2018 | This AHA/ACC special report serves as a companion to the 2018 Cholesterol Clinical Practice Guidelines and 2017 Hypertension Clinical Practice Guidelines.